16
Participants
Start Date
April 30, 2024
Primary Completion Date
October 31, 2024
Study Completion Date
December 31, 2024
Metformin
Metformin is an FDA-approved antidiabetic agent that manages high blood sugar levels in type 2 diabetes patients. However, emerging evidence may suggest a benefit to COVID recovery.
Placebo
Patients will receive matching placebo control twice daily.
Suite No 301, Al-Sehat Centre, Adj Regent Plaza Hotel Rafiqui Shaheed Road, Karachi
Purpose Life Sciences
OTHER